Roseline D'Oiron

Hematologist
Haemophilia Treatment Centre, Bicêtre Hospital, University Hospital of Paris (APHP), Kremlin-Bicêtre, France.

Presentation(s):

• OC 30.5 - Emicizumab Prophylaxis for the Treatment of People with Moderate or Mild Hemophilia A without Factor VIII Inhibitors: Results from the Primary Analysis of the HAVEN 6 Study

  Monday, July 11, 2022
  11:45 AM – 12:00 PM

• PB0686 - Real-world use of recombinant factor IX albumin fusion protein (rIX-FP) in patients with hemophilia B: A prospective, multicenter, non-interventional post-marketing surveillance study in France

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0706 - Pregnancy in women with Factor XI deficiency (<60 UI/dL) and use of neuraxial analgesia : real life data in a French cohort of 314 pregnancies

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB1130 - Real-world evidence on emicizumab in 119 Hemophilia A patients with inhibitors from the French FranceCoag cohort

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM